Citation: W. Hirst et al., INDUCTION OF T-CELL DYSFUNCTION BY LEUKEMIA-DERIVED FACTOR(S) - DIRECT AND INDIRECT MECHANISMS, British Journal of Haematology, 102(1), 1998, pp. 82-83
Authors:
BUGGINS A
HIRST W
DARLING D
GAKEN J
PAGLIUCA A
FARZANEH F
MUFTI GJ
Citation: A. Buggins et al., ABSENCE OF COSTIMULATION AND SECRETION OF TH1 CYTOKINE INHIBITORS CONTRIBUTE TO EVASION OF ANTILEUKEMIC IMMUNITY, British Journal of Haematology, 102(1), 1998, pp. 286-286
Citation: W. Hirst et al., MECHANISMS OF T-CELL DYSFUNCTION IN ACUTE-LEUKEMIA - INTRINSIC T-CELLDEFECT OR SOLUBLE INHIBITORY FACTOR, Blood, 90(10), 1997, pp. 84-84
Citation: A. Buggins et al., PROVISION OF COSTIMULATORY MOLECULES ON MYELOID LEUKEMIC-CELLS ENHANCES T-CELL PROLIFERATION BUT FAILS TO INDUCE CYTOKINE PRODUCTION, Blood, 90(10), 1997, pp. 1231-1231
Authors:
STEPHENSON J
CZEPULKOWSKI B
HIRST W
MUFTI GJ
Citation: J. Stephenson et al., DELETION OF THE ACETYLCHOLINESTERASE LOCUS AT 7Q22 ASSOCIATED WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML), Leukemia research, 20(3), 1996, pp. 235-241
Authors:
HIRST W
DARLING D
GAKEN J
BUGGINS A
BARNARD A
GALEALAURI J
KUIPER M
HOLLIGNSWORTH S
MUFTI G
FARZANEH F
Citation: W. Hirst et al., INDUCTION OF TUMOR REJECTION BY AUTOLOGOUS AND ALLOGENEIC-TUMOR CELLSEXPRESSING B7.1 AND IL-2, Immunology, 89, 1996, pp. 8-8
Authors:
HIRST W
BUGGINS A
DARLING D
GAKEN J
HOLLINGSWORTH S
FARZANEH F
MUFTI GJ
Citation: W. Hirst et al., B7.1 IL-2 GENE-MODIFIED LEUKEMIC-CELLS MAY ACT AS ANTIGEN-PRESENTING CELLS (APCS)/, British Journal of Haematology, 93, 1996, pp. 259-259
Authors:
BUGGINS A
HIRST W
DARLING D
GAKEN J
HOLLINGSWORTH S
FARZANEH F
MUFTI GJ
Citation: A. Buggins et al., ENHANCED IMMUNE COSTIMULATORY ACTIVITY OF PRIMARY HUMAN AML BLASTS FOLLOWING GENE-TRANSFER OF B7.1 (CC80), British Journal of Haematology, 93, 1996, pp. 260-260
Authors:
HOLLINGSWORTH SJ
DARLING D
GAKEN J
HIRST W
PATEL P
KUIPER M
TOWNER P
HUMPHREYS S
FARZANEH F
MUFTI GJ
Citation: Sj. Hollingsworth et al., THE EFFECT OF COMBINED EXPRESSION OF INTERLEUKIN-2 AND INTERLEUKIN-4 ON THE TUMORIGENICITY AND TREATMENT OF B16F10 MELANOMA, British Journal of Cancer, 74(1), 1996, pp. 6-15
Authors:
HOLLINGSWORTH SJ
HIRST W
HUMPHREYS S
BUGGINS A
FARZANEH F
MUFTI GJ
Citation: Sj. Hollingsworth et al., IMMUNE RECONSTITUTION OF SEVERE COMBINED IMMUNE-DEFICIENT (SCID) MICE- A POTENTIAL MODEL FOR TESTING IMMUNE GENE-THERAPY FOR ACUTE MYELOID-LEUKEMIA, European journal of cancer, 31A, 1995, pp. 48-48
Authors:
TOWNER P
DARLING D
GAKEN J
KUIPER M
HOLLINGSWORTH SJ
HIRST W
FARZANEH F
Citation: P. Towner et al., MURINE B16F10 MELANOMA-CELLS AND THE BENEFICIAL-EFFECTS OF IMMUNE MODULATOR GENE TRANSFECTION, Journal of cellular biochemistry, 1995, pp. 427-427
Authors:
BUGGINS A
HIRST W
DARLING D
GAKEN J
FARZANEH F
MUFTI GJ
Citation: A. Buggins et al., RETROVIRUS-MEDIATED GENE-TRANSFER OF B7.1 (CD80) INTO PRIMARY ACUTE MYELOID-LEUKEMIA (AML) CELLS ENHANCES THEIR IMMUNE COSTIMULATORY ACTIVITY, Blood, 86(10), 1995, pp. 1642-1642
Authors:
HIRST W
BUGGINS A
DARLING D
HOLLINGSWORTH S
GAKEN J
FARZANEH F
MUFTI GJ
Citation: W. Hirst et al., COMPARISON OF B7.1 AND INTERLEUKIN-2 (IL-2) IN THE REJECTION OF A MURINE MYELOID-LEUKEMIA, Blood, 86(10), 1995, pp. 1644-1644
Authors:
HIRST W
AGRAWAL S
PARIKH PM
ALLARD S
MEHTA J
POWLES R
TRELEAVEN J
MUFTI GJ
Citation: W. Hirst et al., THE EFFECT OF TRILINEAGE DYSPLASIA ON ENGRAFTMENT IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PRIMARY ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 84, 1993, pp. 27-27
Citation: W. Hirst et Gj. Mufti, THE INTERVAL FROM DIAGNOSIS TO TREATMENT AND BLAST PERCENTAGE INFLUENCES THE OUTCOME OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES(MDS) AND TRILINEAGE DYSPLASIA ACUTE MYELOID-LEUKEMIA (TLD AML)/, British Journal of Haematology, 84, 1993, pp. 34-34
Authors:
HIRST W
PAGLIUCA A
ARYA R
LAYTON DM
HAMBLEY H
BELLINGHAM AJ
Citation: W. Hirst et al., AUTOMATED EXCHANGE RED-CELL TRANSFUSION IN SICKLE-CELL DISEASE USING THE COBE SPECTRA CELL SEPARATOR, British Journal of Haematology, 84, 1993, pp. 65-65